In 1979, Dixon described soft tissue rheumatism as 'the great outback ofRheumatology, a vastfrontier land, iUl-defined and little explained, its features poorly categorised andfarfrom internationally agreed.' Has much changed in the past 15 years?
Soft tissue rheumatism in 1995 Musculoskeletal symptoms without frank arthritis are very common. Most of us suffer such symptoms each year. They usually occur in one region, in an individual who is otherwise well. These regional musculoskeletal disorders, which have commonly been overlooked in the planning and provision of health care, are disorders of major and increasing importance. Soft Perhaps the biggest hindrance to progress in our understanding of soft tissue rheumatism has been a negative attitude to the affected tissues, which are still thought of as inert, homogeneous structures. This is certainly true of diseases where tendon tissues are principally involved.
Tendon diseases
The biological function of a tendon is to pull and transmit muscle power. Rupture-partial or complete-is its worst functional failure, but it may also fail by adhering within its sheath or by stenosis of the sheath. Tendon function can be impaired locally by trauma and in systemic disease, by inflammation and fibrosis, by impairment of blood supply, or by atrophy or degeneration and calcification, and sometimes, in systemic disease, by metabolic deposits.
The role of tendons is often considered to be passive, the tissue relatively inert and very much secondary to other joint structures such as bone, cartilage, and synoviumtissues which have received the greater share of attention. These misconceptions are belied by recent studies investigating human tendon lesions, that demonstrate that these tissues are metabolically active, interesting, and worthy of research. *33% (nine of 27) contained greater than 2 SD above the normal mean
(1-8 ,kg/mg dry wt); the remaining 18 specimens were within the normal range.
Significant differences between groups: *p < 0-05; ***p < 0-001. of different populations of tenocytes and the factors that control tendon cell matrix metabolism (synthesis and turnover).
GROWTH FACTOR AND CYTOKINE STUDIES
Growth factors in general have anabolic effects on tissues, increasing matrix synthesis and reducing matrix breakdown. Cytokines such as interleukin-1 (IL-1) and tumour necrosis factor a often have the opposite effect, decreasing matrix synthesis and upregulating the proteinases that promote matrix breakdown."6 Recent studies have shown that tendons in vitro respond to IL-1 by altering the synthesis of matrix components and proteinases such as the matrix metalloproteinases.'7 "' The production of excessive enzyme activity can exceed that of local inhibitors such as the tissue inhibitors of metalloproteinases and so lead to tissue collagen breakdown. '6 19 Knowledge of the response of aging human tenocytes to cytokines would help determine the role of these factors in the pathological changes found in diseased tendons.
Tendon disease mechanism
These multidisciplinary studies suggest a common disease mechanism (figure), whereby various traumas to the tendon (for example impingement, trauma, hypoxia) induce growth factors that stimulate the tendon fibroblasts, changing the pattern of matrix synthesis. This alteration, with the deposition of tenascin20 and new synthesis of glycosaminoglycan,8 may be a protective response to compression or shear forces. Whatever the cause, these changes are accompanied by cell rounding and an upregulation of proteinases that result in the loosening and then net loss of part of the collagen fibrillar network. In normal tendons these responses are followed by the tendon replacing this altered matrix, and a normal tendon structure reforms. However, in some cases the tendon is unable to repair and irreversible changes in matrix composition then occur. The inappropriate and persistent synthesis of type III collagen, which was found to be increased in 17% of non-ruptured supraspinatus tendons,9 may substantially weaken the tendon matrix and predispose to rupture. Further degradation of the collagen may result from inappropriate action of proteinases. These changes in matrix composition are sometimes followed by the deposition of calcium salts.2' With these changes in composition and structure, even normal loading can cause a rupture of the tendon and subsequent loss of function.
Future prospects Recent advances in the diagnosis and management of the more common syndromes has resulted in better understanding of and care for patients with these varied problems, and there is no good reason why they should remain 'the great outback of Rheumatology'. They do represent a great opportunity for detailed investigation. The careful collection of waste material from human tendon lesions should be followed by biochemical, cell biological, and molecular studies that will allow the confirmation of the proposed disease mechanisms in these metabolically active tissues and so lead to the introduction of new and effective local treatment. As knowledge of the anatomical, biochemical, physical, emotional, and behavioural mechanisms contributing to these syndromes improves, then management will become better standardised and more effective.
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